Fundraising FoxWuXi PharmaTech
5 known investors
Find your way into WuXi PharmaTech
Sign up to find every way you can get introduced to WuXi PharmaTech
- Your email: who you already know at WuXi PharmaTech, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the WuXi PharmaTech team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
WuXi AppTec is a global Contract Research, Development and Manufacturing Organization (CRDMO) that provides integrated drug development services spanning chemistry, biology discovery, preclinical testing, and clinical research across Asia, Europe, and North America. The company serves pharmaceutical innovators seeking to accelerate the development and manufacturing of new therapies in a cost-effective manner.
Investors · 5
HongShan Capital Grouplisted by HongShan Capital GroupHong Kong · $100K – $50M
How we know: hongshan.com · Not right? Tell us
Vivo Capitallisted by Vivo CapitalPalo Alto · $10M – $50M
How we know: Vivo Capital's portfolio page · Not right? Tell us
Legend CapitalreportedBeijing · $2.9M – $156Mvia Frank Hong · inferred
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does WuXi PharmaTech do?
- WuXi AppTec is a global Contract Research, Development and Manufacturing Organization (CRDMO) that provides integrated drug development services spanning chemistry, biology discovery, preclinical testing, and clinical research across Asia, Europe, and North America. The company serves pharmaceutical innovators seeking to accelerate the development and manufacturing of new therapies in a cost-effective manner.
- Who are WuXi PharmaTech's investors?
- WuXi PharmaTech's investors include Highlight Capital, HongShan Capital Group, Huangpu River Capital, Vivo Capital, Legend Capital.